Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : MOVING NOW! -- Ignore unavailable to you. Want to Upgrade?

To: Jorj X Mckie who wrote (6997)	8/28/2001 12:13:21 AM
From: jef saunders	Respond to of 8046

DMTHF is the u.s. symbol for DMX on the toronto exchange. their name is dimethaid research and they have brought to market an arthritis drug. the arthritis drug is not unique, but the delivery system that encompasses the drug is. when the medication is applied to the skin, the medicine is transferred from cell to cell using the cell circuitry. it does not use the blood stream, like every other drug in the world. thus you end up with a truly local delivery. last october, the drug "pennsaid" was approved in england. last week , dimethaid came out with first quarter sales which was only april and may. and in those 2 months they sold $1 million worth of pennsaid. 2 weeks ago, the equivalent of the FDA in england came out and said that pennsaid's largest competitors, vioxx and celebrex , should not be used for arthritis on a regular basis. that's huge. lots of stuff brewing...approval in canada expected by november. 13 countries in europe by november. FDA inspection of mfg plant in november, with approval expected in the u.s. soon after. nasdaq listing by may. the other thing they did was buy out a partner of theirs that has developed a cancer drug that WORKS. results from the phase 3 trial comes out in november. my wife is a nurse and she is super-impressed with what dimethaid has accomplished. we have the boat loaded on this one. i posted here because it went up 12% in one day, but we're in for the long haul on this one. c ya, jeffS